• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cdh1通过调节PPAR/PGC-1α信号通路在非酒精性脂肪性肝病中发挥保护作用。

Cdh1 plays a protective role in nonalcoholic fatty liver disease by regulating PPAR/PGC-1α signaling pathway.

作者信息

Chen Dahua, Dong Xiaoqi, Chen Dawei, Lin Jieqiong, Lu Ting, Shen Jianwei, Ye Hua

机构信息

Department of Gastroenterology, Ningbo Medical Center Lihuili Hospital (Lihuili Hospital Affiliated to Ningbo University), Ningbo, 315040, Zhejiang Province, PR China.

Department of Pulmonary and Critical Care Medicine, Ningbo Medical Center Lihuili Hospital (Lihuili Hospital Affiliated to Ningbo University), Ningbo, 315040, Zhejiang Province, PR China.

出版信息

Biochem Biophys Res Commun. 2023 Nov 12;681:13-19. doi: 10.1016/j.bbrc.2023.09.038. Epub 2023 Sep 17.

DOI:10.1016/j.bbrc.2023.09.038
PMID:37742473
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) is a significant etiological factor in liver-related diseases, which can lead to severe consequences such as steatohepatitis, cirrhosis and death. Cdh1 is considered as a crucial protein involved in cell cycle regulation. The purpose of this study is to explore the biological role of Cdh1 in NAFLD.

MATERIALS AND METHODS

NAFLD cell model was established, and L02 cells and AML12 cells were infected by shRNA lentivirus with Cdh1 knockdown in vitro, and the effect of Cdh1 deletion on cell lipid deposition was evaluated. The effects of Cdh1 deletion on Akt phosphorylation and PPAR/PGC-1α signaling pathway in L02 cells were examined. In addition, the NAFLD mouse model was constructed, and the conditional knockout mice of Cdh1 were selected to verify the results.

RESULTS

In vitro experiments showed that the Cdh1 deletion enhanced cell lipid deposition. In vivo experiments showed that conditional knockdown of Cdh1 aggravated fatty degeneration and damage of liver in mice. Cdh1 deletion promotes Akt phosphorylation and inhibits PPAR/PGC-1α signaling pathway in L02 cells. Conditional knockout of Cdh1 down-regulates PPAR/PGC-1α signaling pathway in NAFLD mouse model.

CONCLUSION

The deletion of Cdh1 may promote Akt phosphorylation by up-regulating Skp2 and inhibit the PPAR/PGC-1α signaling pathway. Cdh1 serves a protective function in the occurrence and progression of NAFLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是肝脏相关疾病的一个重要病因,可导致诸如脂肪性肝炎、肝硬化和死亡等严重后果。Cdh1被认为是参与细胞周期调控的关键蛋白。本研究的目的是探讨Cdh1在NAFLD中的生物学作用。

材料与方法

建立NAFLD细胞模型,在体外通过shRNA慢病毒感染L02细胞和AML12细胞以敲低Cdh1,评估Cdh1缺失对细胞脂质沉积的影响。检测Cdh1缺失对L02细胞中Akt磷酸化和PPAR/PGC-1α信号通路的影响。此外,构建NAFLD小鼠模型,选择Cdh1条件性敲除小鼠以验证结果。

结果

体外实验表明,Cdh1缺失增强了细胞脂质沉积。体内实验表明,Cdh1的条件性敲低加重了小鼠肝脏的脂肪变性和损伤。Cdh1缺失促进L02细胞中Akt磷酸化并抑制PPAR/PGC-1α信号通路。在NAFLD小鼠模型中,Cdh1的条件性敲除下调了PPAR/PGC-1α信号通路。

结论

Cdh1的缺失可能通过上调Skp2促进Akt磷酸化并抑制PPAR/PGC-1α信号通路。Cdh1在NAFLD的发生和发展中起保护作用。

相似文献

1
Cdh1 plays a protective role in nonalcoholic fatty liver disease by regulating PPAR/PGC-1α signaling pathway.Cdh1通过调节PPAR/PGC-1α信号通路在非酒精性脂肪性肝病中发挥保护作用。
Biochem Biophys Res Commun. 2023 Nov 12;681:13-19. doi: 10.1016/j.bbrc.2023.09.038. Epub 2023 Sep 17.
2
Rosmarinic acid exerts an antagonistic effect on nonalcoholic fatty liver disease by regulating the YAP1/TAZ-PPARγ/PGC-1α signaling pathway.迷迭香酸通过调节 YAP1/TAZ-PPARγ/PGC-1α 信号通路对非酒精性脂肪性肝病发挥拮抗作用。
Phytother Res. 2021 Feb;35(2):1010-1022. doi: 10.1002/ptr.6865. Epub 2020 Sep 11.
3
Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway.沉默 HIF-1α 通过抑制 PPAR-α/ANGPTL4 信号通路加重体外非酒精性脂肪性肝病。
Gastroenterol Hepatol. 2021 May;44(5):355-365. doi: 10.1016/j.gastrohep.2020.09.014. Epub 2020 Oct 23.
4
Elucidation of SIRT-1/PGC-1α-associated mitochondrial dysfunction and autophagy in nonalcoholic fatty liver disease.阐明非酒精性脂肪性肝病中 SIRT-1/PGC-1α 相关的线粒体功能障碍和自噬。
Lipids Health Dis. 2021 Apr 26;20(1):40. doi: 10.1186/s12944-021-01461-5.
5
LB100 ameliorates nonalcoholic fatty liver disease the AMPK/Sirt1 pathway.LB100 通过 AMPK/Sirt1 通路改善非酒精性脂肪性肝病。
World J Gastroenterol. 2019 Dec 7;25(45):6607-6618. doi: 10.3748/wjg.v25.i45.6607.
6
Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.缺氧通过 HIF-2α/PPARα 通路加重非酒精性脂肪性肝病。
Am J Physiol Endocrinol Metab. 2019 Oct 1;317(4):E710-E722. doi: 10.1152/ajpendo.00052.2019. Epub 2019 Aug 20.
7
[Mechanism of Zexie Decoction in improvement of nonalcoholic fatty liver disease based on LKB1/AMPK/PGC-1α pathway].基于LKB1/AMPK/PGC-1α通路探讨泽泻汤改善非酒精性脂肪性肝病的机制
Zhongguo Zhong Yao Za Zhi. 2022 Jan;47(2):453-460. doi: 10.19540/j.cnki.cjcmm.20211008.402.
8
Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.基于网络药理学和小型猪验证的复方珍珠调脂胶囊治疗 2 型糖尿病合并非酒精性脂肪肝病的分子机制。
J Ethnopharmacol. 2021 Jun 28;274:114056. doi: 10.1016/j.jep.2021.114056. Epub 2021 Mar 23.
9
High-fat diet inhibits PGC-1α suppressive effect on NFκB signaling in hepatocytes.高脂饮食抑制过氧化物酶体增殖物激活受体 γ 共激活因子 1α 对肝细胞中 NFκB 信号的抑制作用。
Eur J Nutr. 2018 Aug;57(5):1891-1900. doi: 10.1007/s00394-017-1472-5. Epub 2017 May 24.
10
Digeda-4 decoction and its disassembled prescriptions improve dyslipidemia and apoptosis by regulating AMPK/SIRT1 pathway on tyloxapol-induced nonalcoholic fatty liver disease in mice.地丹四逆汤拆方对他丁醇诱导的非酒精性脂肪肝病小鼠脂代谢紊乱及细胞凋亡的影响及其作用机制
J Ethnopharmacol. 2023 Dec 5;317:116827. doi: 10.1016/j.jep.2023.116827. Epub 2023 Jun 20.

引用本文的文献

1
Ginkgolide B attenuates hyperlipidemia by restoring sphingolipid homeostasis and activating PPARα and Nrf2 pathways.银杏内酯B通过恢复鞘脂稳态以及激活过氧化物酶体增殖物激活受体α(PPARα)和核因子E2相关因子2(Nrf2)信号通路来减轻高脂血症。
Sci Rep. 2025 Aug 6;15(1):28774. doi: 10.1038/s41598-025-14626-4.
2
Gene-by-environment Interactions and Adaptive Body Size Variation in Mice From the Americas.美洲小鼠中基因与环境的相互作用及适应性体型变异
Mol Biol Evol. 2025 Apr 1;42(4). doi: 10.1093/molbev/msaf078.
3
A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver.
肝脂肪变性的预后分子特征在人类肝脏中具有空间异质性且是动态变化的。
Cell Rep Med. 2024 Dec 17;5(12):101871. doi: 10.1016/j.xcrm.2024.101871. Epub 2024 Dec 9.
4
Potential of the Novel Slot Blot Method with a PVDF Membrane for Protein Identification and Quantification in Kampo Medicines.用于汉方药中蛋白质鉴定和定量的新型聚偏二氟乙烯膜狭缝印迹法的潜力。
Membranes (Basel). 2023 Dec 1;13(12):896. doi: 10.3390/membranes13120896.